Pearls in Writing · From the Podcast
Wellbutrin vs Trintellix: Dopamine Boost or Serotonin Fine-Tuning After an SSRI Falls Short?
When an SSRI lifts the depression scores but leaves a patient's joy, motivation, and emotional range flat, the next move hinges on one distinction: residual depression, or SSRI-induced emotional blunting? This flash-card summary of the Pearls and Prep episode breaks down the two classic answers — Wellbutrin (bupropion) and Trintellix (vortioxetine). Flip each card for the decision rules, doses, and pitfalls.
🎧 From the episode: Wellbutrin (Bupropion) vs Trintellix (Vortioxetine) After SSRI Failure
Name the Problem: Emotional Blunting vs Residual Depression
Improved scores, flat life — what is actually going on?
Tap to flip
- Two look-alikes: residual depression and SSRI-induced emotional blunting — they demand opposite moves.
- Blunting is a serotonergic side effect: more of the same SSRI will not fix it (Street Take).
- SSRIs quiet the salience network — amygdala, insula, anterior cingulate, ventral striatum — the circuitry that tags things as important.
- Imaging discussed in the episode: reduced neural response to both aversive and rewarding cues.
- Ask about joy, motivation, and emotional range — not just sadness scores.
The SSRI is working. Scrap it, or build on it?
Tap to flip
- If the SSRI won on the core syndrome — less tearful, less reactive, less ruminative — do not reflexively abandon it.
- Usual move: augment around the blunting rather than discarding a winning drug.
- Dose-lowering can ease blunting but may also undercut the antidepressant response.
- Inventory exactly what the SSRI fixed before you decide anything.
Wellbutrin (Bupropion): The Dopamine Pivot After SSRI Failure
Why is Wellbutrin the pivot for flat and unmotivated?
Tap to flip
- NDRI: blocks norepinephrine and dopamine reuptake; leaves serotonin alone.
- Counters the serotonergic brake on dopamine in reward and motivation circuits.
- Street Take: "Wellbutrin's the pivot for flat and unmotivated: dopaminergic, activating, no sexual side effects."
- Classic pairing: SSRI + Wellbutrin — two transmitters, two circuits, "wine and cheese."
The ideal Wellbutrin patient looks like…
Tap to flip
- Sluggish, low-energy, low-motivation depression; struggling with basic tasks and self-care.
- Sexual side effects on an SSRI — bupropion does not carry the serotonergic sexual burden.
- Weight concerns: weight-neutral, and some patients lose a little.
- Bonus lanes: smoking cessation benefit; possible subthreshold ADHD features.
- Seasonal pattern: Wellbutrin XL is FDA-approved to prevent seasonal affective disorder episodes (FDA label).
Wellbutrin pitfalls — what stops you?
Tap to flip
- Seizure risk is dose-related.
- FDA label contraindications: seizure disorder; current or prior anorexia or bulimia.
- Dose in the morning — it is activating.
- Core picture is anxious, ruminative, threat-focused? Pure dopamine-chasing may miss; that patient may still need the serotonin lane.
Trintellix (Vortioxetine): The Multimodal Serotonin Fine-Tuner
What does "multimodal" actually mean here?
Tap to flip
- Not an antipsychotic, not a plain SSRI: SERT blockade plus direct serotonin-receptor tuning.
- 5-HT1A agonist · 5-HT1B partial agonist · 5-HT3 antagonist, among other subtype actions.
- 5-HT3 blockade on GABA interneurons releases dopamine, norepinephrine, acetylcholine, histamine, and glutamate downstream.
- Proposed result: a more activating profile with less blunting — and a pro-cognitive signal.
Trintellix's case: cognition
Tap to flip
- Street Take: "Trintellix's case is cognition — multimodal serotonergic, with actual pro-cognitive data behind it."
- Best-fit picture: depression with brain fog, slow processing, poor concentration.
- FDA-approved for major depressive disorder in adults only — not FDA-approved for anxiety disorders (FDA label).
- Fits the serotonergic-dominant patient who still needs serotonin but cannot tolerate SSRI blunting or sexual effects.
Trintellix pitfalls
Tap to flip
- Nausea is the headline side effect, and it is dose-related; taking it with food may help.
- Also: vomiting, dry mouth, diarrhea.
- Sexual dysfunction risk is comparatively favorable at lower doses — and rises with dose.
- Strong CYP2D6 inhibitors or poor metabolizers: dose adjustment per the FDA label.
- Brand-name cost: expect prior authorizations.
Augment or Switch? The Bupropion–Vortioxetine Decision Rule
The decision rule, on one card
Tap to flip
- SSRI carrying real wins + blunting on top → augment with Wellbutrin.
- Still needs serotonin, with cognition, blunting, or sexual effects driving → switch within the lane to Trintellix.
- Street Take: name the flatness with your patient — "this has a name and a fix" — and buy-in follows.
⚡ Rapid-Fire Recap
- Blunting ≠ residual depression — separate them before you prescribe.
- Wellbutrin = dopamine pivot (NDRI): drive and energy, no serotonergic sexual burden; respect the seizure contraindications.
- Trintellix = serotonin fine-tuner: cognition data, MDD-only label, nausea tax.
- Augment a winning SSRI; switch a wrong-lane one. Never switch on reflex.
📖 Sources & further reading
- FDA prescribing information: WELLBUTRIN XL (bupropion), including seizure contraindications and the seasonal affective disorder prevention indication — DailyMed.
- FDA prescribing information: TRINTELLIX (vortioxetine), including the major depressive disorder indication and CYP2D6 dose adjustments — DailyMed.
- U.S. Department of Veterans Affairs / Department of Defense. Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) — PubMed.
- Lam RW, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Can J Psychiatry. 2024 — PubMed.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.
New here? Start with the free door: join Pearls and Prep on Patreon free and get the 50 High-Yield Pearls study guide, or go straight to the topic-labeled collections built from the full episode library.
Ready to feel ready for your first patient? Boss Pearl members unlock the full clinical library — every psychopharm deep dive, the Case Crunch challenges, and the 100 Interview Tips eBook — the bridge from knowing psychiatry to walking in confident.
⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship.